These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 27424208)
1. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins. Teo CR; Casey PJ; Rasheed SA Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells. Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182 [TBL] [Abstract][Full Text] [Related]
3. GNA13 suppresses proliferation of ER+ breast cancer cells via ERα dependent upregulation of the MYC oncogene. Subramanyan LV; Rasheed SAK; Wang L; Ghosh S; Ong MSN; Lakshmanan M; Wang M; Casey PJ Breast Cancer Res; 2024 Jul; 26(1):113. PubMed ID: 38965558 [TBL] [Abstract][Full Text] [Related]
4. Gα12/13 signaling promotes cervical cancer invasion through the RhoA/ROCK-JNK signaling axis. Yuan B; Cui J; Wang W; Deng K Biochem Biophys Res Commun; 2016 May; 473(4):1240-1246. PubMed ID: 27084452 [TBL] [Abstract][Full Text] [Related]
5. Gene Expression of Kallikreins in Breast Cancer Cell Lines. Watrowski R; Castillo-Tong DC; Obermayr E; Zeillinger R Anticancer Res; 2020 May; 40(5):2487-2495. PubMed ID: 32366393 [TBL] [Abstract][Full Text] [Related]
6. Gα-13 induces C Lim WK; Chai X; Ghosh S; Ray D; Wang M; Rasheed SAK; Casey PJ J Biol Chem; 2019 Nov; 294(48):18192-18206. PubMed ID: 31636124 [TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells. Sun K; Duan X; Cai H; Liu X; Yang Y; Li M; Zhang X; Wang J Clin Exp Med; 2016 Feb; 16(1):37-47. PubMed ID: 25596714 [TBL] [Abstract][Full Text] [Related]
8. Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration. Scarlett KA; White EZ; Coke CJ; Carter JR; Bryant LK; Hinton CV Mol Cancer Res; 2018 Apr; 16(4):728-739. PubMed ID: 29330286 [TBL] [Abstract][Full Text] [Related]
9. Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells. O'Hayre M; Inoue A; Kufareva I; Wang Z; Mikelis CM; Drummond RA; Avino S; Finkel K; Kalim KW; DiPasquale G; Guo F; Aoki J; Zheng Y; Lionakis MS; Molinolo AA; Gutkind JS Oncogene; 2016 Jul; 35(29):3771-80. PubMed ID: 26616858 [TBL] [Abstract][Full Text] [Related]
10. Kallikreins as microRNA targets: an in silico and experimental-based analysis. Chow TF; Crow M; Earle T; El-Said H; Diamandis EP; Yousef GM Biol Chem; 2008 Jun; 389(6):731-8. PubMed ID: 18627289 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells. Rasheed SAK; Teo CR; Beillard EJ; Voorhoeve PM; Casey PJ J Biol Chem; 2013 Mar; 288(11):7986-7995. PubMed ID: 23329838 [TBL] [Abstract][Full Text] [Related]
13. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction. Zhang C; Wang HJ; Bao QC; Wang L; Guo TK; Chen WL; Xu LL; Zhou HS; Bian JL; Yang YR; Sun HP; Xu XL; You QD Oncotarget; 2016 Nov; 7(45):73593-73606. PubMed ID: 27713154 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway. Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430 [TBL] [Abstract][Full Text] [Related]
15. G12 signaling through c-Jun NH2-terminal kinase promotes breast cancer cell invasion. Juneja J; Cushman I; Casey PJ PLoS One; 2011; 6(11):e26085. PubMed ID: 22087220 [TBL] [Abstract][Full Text] [Related]
16. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo. Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers. Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462 [TBL] [Abstract][Full Text] [Related]
18. Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway. Lang JY; Chen H; Zhou J; Zhang YX; Zhang XW; Li MH; Lin LP; Zhang JS; Waalkes MP; Ding J Clin Cancer Res; 2005 May; 11(9):3455-64. PubMed ID: 15867248 [TBL] [Abstract][Full Text] [Related]
19. Parallel overexpression of seven kallikrein genes in ovarian cancer. Yousef GM; Polymeris ME; Yacoub GM; Scorilas A; Soosaipillai A; Popalis C; Fracchioli S; Katsaros D; Diamandis EP Cancer Res; 2003 May; 63(9):2223-7. PubMed ID: 12727843 [TBL] [Abstract][Full Text] [Related]
20. Activation of choline kinase by extracellular Ca2+ is Ca(2+)-sensing receptor, Galpha12 and Rho-dependent in breast cancer cells. Huang C; Hydo LM; Liu S; Miller RT Cell Signal; 2009 Dec; 21(12):1894-900. PubMed ID: 19716891 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]